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Background: Vancomycin-resistant Enterococcus faecium (VREfm) has emerged as a nosocomial pathogen
worldwide. The dissemination of VREfm is due to both clonal spread and spread of mobile genetic elements
(MGEs) such as transposons.
Objectives: We aimed to combine vanB-carrying transposon data with core-genome MLST (cgMLST) typing and
epidemiological data to understand the pathways of transmission in nosocomial outbreaks.
Methods: Retrospectively, 36 VREfm isolates obtained from 34 patients from seven VREfm outbreak investiga-
tions in 2014 were analysed. Isolates were sequenced on a MiSeq and a MinION instrument. De novo assembly
was performed in CLC Genomics Workbench and the hybrid assemblies were obtained through Unicycler v0.4.1.
Ridom SeqSphere! was used to extract MLST and cgMLST data. Detailed analysis of each transposon and their
integration points was performed using the Artemis Comparison Tool (ACT) and multiple blast analyses.
Results: Four different vanB transposons were found among the isolates. cgMLST divided ST80 isolates into three
cluster types (CTs); CT16, CT104 and CT106. ST117 isolates were divided into CT24, CT103 and CT105. Within
VREfm isolates belonging to CT103, two different vanB transposons were found. In contrast, VREfm isolates
belonging to CT104 and CT106 harboured an identical vanB transposon.
Conclusions: cgMLST provides a high discriminatory power for the epidemiological analysis of VREfm. However,
additional transposon analysis is needed to detect horizontal gene transfer. Combining these two methods
allows investigation of both clonal spread as well as the spread of MGEs. This leads to new insights and thereby
better understanding of the complex transmission routes in VREfm outbreaks.
Introduction
Enterococcus faecium has emerged as a nosocomial pathogen
worldwide. Vancomycin-resistant E. faecium (VREfm) outbreaks
are mainly caused by successful hospital-associated (HA)
E. faecium isolates that have acquired the vanA or vanB gene.1 The
dissemination of VREfm is the result of both clonal spread of suc-
cessful clones, mainly ST17, ST18 and ST78,2 and the exchange of
mobile genetic elements (MGEs) such as chromosomal fragments3
and plasmids.1,4,5 The vanA gene is part of an operon of seven
genes, carried by the Tn1546 transposon, which can be located on
various plasmid types or can be integrated into the chromo-
some.6,7 Similarly to vanA, vanB is also part of an operon that con-
sists of seven genes, generally located on the conjugative
transposon Tn1549/Tn5382. Like Tn1546, this transposon can also
be located on various types of plasmids or can be integrated into
the chromosome.1,4
In our hospital, we mainly find vanB VREfm. Successful HA
vancomycin-susceptible E. faecium (VSEfm) lineages may acquire
the vanB gene by different pathways. It can occur by de novo ac-
quisition of Tn1549 from anaerobic gut microbiota.8 Another
mechanism is through the exchange of large chromosomal frag-
ments, including Tn1549, between vanB VREfm and VSEfm.3
In outbreak investigations, rapid and accurate typing is required
to investigate the genetic relatedness between patient isolates.
This information is essential to demonstrate nosocomial transmis-
sion. Till 2014, most VREfm isolates in our hospital were typed by
multi-locus variable-number tandem repeat analysis (MLVA).
MLVA is an easy, fast and highly reproducible method to type
VREfm,9 but not discriminatory enough in outbreak investigations.
VC The Author(s) 2018. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecom-
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MLST is a key tool to study the genetic relatedness and epidemi-
ology of E. faecium isolates.10 However, the discriminatory power
of MLST is also insufficient in nosocomial outbreak investigations.11
In addition to its inferior discriminatory power, MLST-based typing
may be unreliable due to recombination events in the MLST loci,
which can cause a high number of discrepancies between WGS-
based typing and MLST.8,12,13
In 2014, WGS was implemented in our laboratory for outbreak
investigations of MDR microorganisms, including VREfm.14 The
challenge of using WGS is to rapidly analyse and interpret the rele-
vant information.15,16 In 2015, a core-genome (cg) MLST scheme
(consisting of 1423 target genes) for E. faecium was developed.17
This gene-by-gene typing-based approach uses a defined set of
genes to extract an allele-based profile which makes it scalable
and comparable between laboratories. However, cgMLST may also
be misleading if horizontal transfer of a single vanB-carrying trans-
poson occurs between different E. faecium clones during a VREfm
outbreak event.
In this study, we retrospectively analysed available draft gen-
ome sequences of VREfm isolates from several outbreaks in 2014
in our region and investigated relevant epidemiological data. Next,
a detailed characterization of vanB-carrying transposons was per-
formed to determine possible horizontal gene transfer. We used
these techniques to investigate spread by clonal expansion as well
as by horizontal gene transfer.
Methods
Study population and infection control protocols
We retrospectively analysed VREfm outbreaks that occurred in the
University Medical Center Groningen (UMCG), The Netherlands in 2014. In
2014, 75 new patients with VREfm were detected. Microbiological data and
infection records were used. Infection records included epidemiological in-
formation about VRE-positive patients. Epidemiological data included dates
of when patients were found to be positive, ward and room numbers, pa-
tient transfer data and microbiological typing data. We also made use of an
epidemiological program to visualize and analyse patient transfers in more
detail over several wards and rooms in time by using bed occupancy data-
bases. Herein multiple patients and wards could be included. From 2014
on, concurrent VRE outbreaks have arisen, as experienced by many hospi-
tals in the Netherlands.
As routine, we screen the following patients for VRE upon admission:
patients who have been admitted to a hospital abroad within the past year;
patients directly transferred from another hospital in the Netherlands;
patients who are admitted to the intensive care and haematology wards;
and adopted children. In the Netherlands, it is recommended to screen
adopted children for MRSA, as they are frequently from countries that are
highly endemic for MRSA. We have chosen to extend the screening in
adopted children, by screening for all highly resistant microorganisms
(HRMOs), including VRE. Patients previously known to carry VRE of which the
last positive VRE culture was ,1 year ago, are treated in contact isolation
and additional rectal swabs are taken for VRE screening. At least five nega-
tive rectal swabs are needed to discard the isolation measures in VRE-
positive patients and those that were known to carry VRE ,1 year ago.
Patients previously known to carry VRE .1 year ago are treated in contact
isolation, unless one or more negative previous VRE cultures were recorded.
An additional rectal swab is taken for VRE screening. If this is negative, isola-
tion measures can be discarded. Patients carrying VRE are treated in con-
tact isolation in a single room, using a disposable gown and gloves by the
personnel. Screening of contact patients is performed if there has been ex-
posure of other patients in the same room, or if nosocomial acquisition of
VRE is suspected. Since not all patients in our hospital are routinely
screened, nosocomial acquisition (e.g. .48 h after admission) is difficult to
define. However, in cases of VRE-positive patients who were previously
screened VRE negative and in situations of ongoing VRE spread, this is con-
sidered as nosocomial acquisition. Screening of contact patients is per-
formed as follows: first, (ex-)roommates of the VRE-positive patient will be
screened. If there are one or more VRE-positive contact patients, all
patients on the ward and, if relevant, ex-patients that have stayed in the
affected ward will be screened. The screening is repeated until no new posi-
tive VRE patients are detected in at least three rounds of screening, where
at least 48 h between each screening round is required. On average, the
last screening round will be 7 days after (possible) exposure since transmis-
sion and subsequent rectal colonization takes time.18
VRE culture
VRE culture was preceded by PCR screening as described previously.19 In
brief, rectal swabs were inoculated in enrichment broth. After 24 h incuba-
tion, a vanA/vanB PCR (XpertV
R
vanA/vanB, Cepheid) was performed on a
GeneXpertV
R
XVI (Cepheid) and when positive the broth was subcultured on
VRE Brilliance agar (OxoidV
R
). Agar was incubated for 24–48 h and identifica-
tion and antibiotic susceptibility testing were performed on suspected colo-
nies by MALDI-TOF Mass Spectrometry (Bruker) and VITEKV
R
2 (bioMe´rieux),
respectively. Additionally, we used vancomycin disc diffusion since this
method is more sensitive in detecting enterococcal isolates with low- and
medium-level vanB-type vancomycin resistance.20 Moreover, identified
E. faecium isolates were again genotypically tested for the presence of
vanA and vanB genes by PCR using the XpertV
R
vanA/vanB assay.
As standard, all first VREfm isolates of each patient were typed by MLVA,
according to the method described by Top et al.9 In some cases,
e.g. patients that were infected as well as colonized by VRE or harbouring
vanA as well as vanB VRE, multiple VRE isolates were typed. In 2014, we
started to implement WGS for VREfm outbreak investigations. In this imple-
mentation phase, only a representative subset of isolates that were typed
by MLVA were selected for WGS and typed by cgMLST.
WGS and typing methods
Genomic DNA was extracted using the Ultraclean Microbial DNA Isolation
Kit (MO BIO Laboratories, Carlsbad, CA, USA) following the manufacturer’s
instructions. The DNA concentration and purity were measured by
the Qubit dsDNA HS and BR assay kit (Life Technologies, Carlsbad, CA, USA).
A DNA library was prepared using the Nextera XT v2 kit (Illumina, San Diego,
CA, USA) and then run on a MiSeq sequencer (Illumina) to generate paired-
end 250 bp reads. De novo assembly was performed by CLC Genomics
Workbench v7.0.4 (QIAGEN, Hilden, Germany) after quality trimming (Qs
20) with optimal word sizes. All procedures were performed as previously
described.21 For the long-read sequencing, libraries of samples A13, A16,
A20 and A22 were prepared without shearing to maximize sequencing
read length. Samples were barcoded with the Native Barcoding Kit 1D (EXP-
NBD103) and libraries were prepared using the Ligation Sequencing Kit 1D
(SQK-LSK108). The library was loaded onto a FLO-MIN106 R9.4 flow cell
and run on a MinION device (48 h). Base calling was performed using
Albacore v1.2.2. Data quality was analysed through Poretools v0.6.0.22
Hybrid assemblies were performed using Unicycler v0.4.1.23 Bandage
v0.8.124 was used to visualize the assembly graphics. Genes of interest
were detected using ResFinder.
MLST STs and cgMLST cluster types (CTs) were extracted from the
draft genomic sequences using SeqSphere! version 3.0.1 (Ridom GmbH,
Mu¨nster, Germany). For the cgMLST analysis, Seqsphere! used the
E. faecium scheme published previously,17 considering a cluster alert dis-
tance of 20 different alleles. The vanB-carrying transposons were identified
by BLAST comparisons of de novo and hybrid assemblies with the reference
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(http://www.webact.org/WebACT/home)25 under default settings. Detailed
analysis of each transposon as well as their integration points was per-
formed using ACT26 and multiple blast analyses.
Ethics
The bacterial isolates used for the present analyses were collected in the
course of routine diagnostics and infection prevention control. Oral consent
for the use of such clinical samples for research purposes is routinely
obtained upon patient admission to the UMCG, in accordance with the
guidelines of the Medical Ethics Committee of the UMCG. All experiments
were performed in accordance with the guidelines of the Declaration of
Helsinki and the institutional regulations and all samples were
anonymized.
Nucleotide sequence accession numbers
Sequence data obtained in this study have been deposited at the European
Nucleotide Archive (ENA) under BioProject no. PRJEB25590. The hybrid
assemblies have been deposited in NCBI under BioProject no PRJNA477347.
Results
Description of outbreak clusters based on
epidemiological data
During the implementation period of WGS, 36 representative iso-
lates from 34 patients were sequenced and their draft genome
sequences were available for analysis. Based on epidemiological
data from infection prevention records, these 34 patients were
involved in six outbreak episodes on seven different wards in 2014.
All first VRE isolates of individual cases were assessed, except for
two patients from whom multiple isolates were selected for
sequencing (A4 and A4.1; plus A22 and A22.1).
Details of the isolates and to which outbreak investigation they
belonged are presented in Table 1. Initial outbreak investigations
were performed using epidemiological information as described in
the Methods section. Outbreak investigation A took place in April
2014 on ward 1 and 12 patients were involved. For 10 of these
patients, the genome sequences of the obtained isolates (A1 and
A4–A13, including A4.1) were available. One of the patients (A1)
admitted to ward 1 was previously hospitalized in another hospital
located in the region. Two isolates (A2 and A3) were therefore
obtained from possible contact patients from the other regional
hospital and were included in this analysis. Outbreak investigation
B took place in July 2014 on ward 1 and four patients were
involved. The genome sequences of the obtained isolates (A14 and
A15) were available for two patients. Outbreak investigation C took
place in July 2014 on wards 5 and 6 and 10 patients were involved.
Genome sequences of the obtained isolates (A16–A20) were avail-
able for five of these patients. According to epidemiological data,
outbreak investigation D took place in November 2014 on ward 7
and involved a total of 11 patients. The genome sequences of the
obtained isolates (A21–A28) were available for eight of these
patients. Also in November 2014, outbreak investigation E took
place on ward 2, involving 11 patients. The genome sequences of
the obtained isolates (A29–A31) were available for three of these
patients. Finally, outbreak investigation F took place in December
2014 on several wards, involving seven patients. The genome
sequences of the obtained isolates (A32–A34) were available from
three patients on a selected ward (ward 4).
Patients A22 and A27 were colonized with E. faecium isolates
carrying both the vanA and the vanB genes. The vanA gene resided
on the chromosome, while the vanB gene was located on a plas-
mid. This study will further focus on the vanB VREfm and Tn1549/
Tn5382 transposon analysis since the rest of the patients were
colonized with only vanB VREfm.
Discrepancies between epidemiological links and
typing results
Initial MLVA typing showed three MLVA types (MTs); MT1 (n"12),
MT12 (n"23) and MT144 (n"1) (Table 1). Based on MLST typing,
the isolates belonged to ST80 (n"12), ST117 (n"23) and ST262
(n"1). The clusters based on MLVA and MLST matched, except for
isolate A9. cgMLST typing identified seven different clusters: CT103
(n"11), CT24 (n"11), CT104 (n" 8), CT105 (n"1), CT106 (n"3),
CT60 (n"1) and CT16 (n"1) (Table 1). The minimum spanning
tree of the cgMLST typing results of the 36 sequenced isolates is
shown in Figure 1.
In outbreak investigation A, the typing results of MLVA, MLST
and cgMLST confirmed that 11 out of the 14 isolates were genetic-
ally related. These isolates belonged to CT24 whereas the isolates
A13 and A9 were from CT103 and CT16, respectively. Isolate A4.1
from patient A4, from whom two isolates were sequenced, is dis-
cussed below. Patient A13 was initially considered as the index pa-
tient of the outbreak investigation A, because the patient was
known to be colonized with VREfm already in March 2013.
However, patient A13 was associated with another outbreak inves-
tigation which is discussed below. Based on the cgMLST results, pa-
tient A1 was eventually found to be the most likely index patient of
the outbreak. As mentioned earlier, this patient was transferred
from another regional hospital. Interestingly, the isolates of the
three patients from the regional hospital (A1–A3), clustered to-
gether with the isolates (A4–A8 and A10–12) obtained from eight
patients in our hospital. Isolate A9 belonged to CT16 and eventual-
ly could not be linked with any of the outbreaks. The two isolates
from outbreak investigation B were totally different based on
MLVA, MLST and cgMLST. In the case of outbreak investigation C,
MLST showed two isolates belonging to ST80 and three isolates
belonging to ST117. The cgMLST results identified the presence of
three CTs among the isolates in this outbreak investigation: CT103,
CT104 and CT105. By MLVA and MLST typing, isolates of outbreak
investigation D could not be discriminated but cgMLST divided
them into two distinct clusters: five isolates belonged to CT104,
and three to CT106. The isolates of CT106 were vanA/vanB co-
producers. Based on cgMLST, the three isolates from outbreak in-
vestigation E belonged to CT103 as well as the three isolates from
outbreak investigation F.
vanB-carrying transposon characterization
Based on the de novo assemblies and the hybrid assemblies gener-
ated from sequencing data of the 36 VREfm isolates, the vanB-car-
rying transposons and the genomic locations of these MGEs were
investigated in more detail. Unfortunately, isolates A9 and A14 lost
the vanB gene and were therefore excluded from this analysis.
Four different transposons carrying the vanB operons were
detected, further referred to as transposon types 1, 2, 3 and
4 (Figure 2).
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Transposon type 1 was detected in all 13 VREfm isolates
belonging to CT24 (A1–A8 and A10–12) and in one isolate belong-
ing to CT103 (A4.1). The overall DNA sequence of this transposon
was similar to the previously described transposon Tn1549/
Tn5382 (GenBank: AF192329.1) with 99 SNP differences. In all 14
isolates, the identical vanB transposon was located on the bacter-
ial chromosome integrated into the phosphoesterase gene
(Genbank locus_taq: BO233_04565). Interestingly, isolates A4
with CT24 and A4.1 with CT103 were obtained from the same pa-
tient and both carried transposon type 1. In total, six isolates from
the rectum and bile were collected from patient A4 in the period
from April till October 2014. We decided to sequence these add-
itional six strains to verify this observation. Indeed, two isolates
from the rectum (A4.1 and A4.2) belonged to CT103. Two isolates
from the rectum (A4.3 and A4.4) and two from bile (A4 and A4.5)
belonged to CT24. Details are shown in Table S1 (available as
Supplementary data at JAC Online). Again, all six VREfm isolates
harboured the identical vanB transposon (transposon type 1) with
identical insertion sites.
Transposon type 2 was detected in 10 isolates belonging to
CT103 (A13, A15, A18, A19 and A29–A34). This transposon was
found to be integrated into the plasmid DNA invertase Pin gene

















A1 A Apr 1 43 M vanB 8 rectal swab 12 117 24 8/3/2014 chromosome 1
A2 A Apr c 73 M vanB 8 rectal swab 12 117 24 16/5/2014 chromosome 1
A`3 A Apr c 76 M vanB 8 sputum 12 117 24 19/5/2014 chromosome 1
A4 A Apr 1 65 F vanB 32 bile 12 117 24 1/4/2014 chromosome 1
A4.1 A Apr 1 65 F vanB 32 rectal swab 12 117 103 13/5/2014 chromosome 1
A5 A Apr 1 67 F vanB 32 rectal swab 12 117 24 16/4/2014 chromosome 1
A6 A Apr 1 69 F vanB 32 rectal swab 12 117 24 16/4/2014 chromosome 1
A7 A Apr 1 59 M vanB 32 rectal swab 12 117 24 21/4/2014 chromosome 1
A8 A Apr 1 82 F vanB 8 rectal swab 12 117 24 24/4/2014 chromosome 1
A9 A Apr 1 59 M vanB 8 rectal swab 12 80 16 29/4/2014 ND ND
A10 A Apr 1 69 F vanB 8 rectal swab 12 117 24 1/5/2014 chromosome 1
A11 A Apr 1 67 M vanB 32 rectal swab 12 117 24 4/5/2014 chromosome 1
A12 A Apr 1 77 M vanB 8 rectal swab 12 117 24 2/4/2014 chromosome 1
A13 A Apr 1 61 F vanB 32 rectal swab 12 117 24 29/4/2014 plasmid 2
A14 B Jul 1 61 M vanB 0.5 rectal swab 144 262 60 29/6/2014 ND ND
A15 B Jul 1 78 M vanB 8 rectal swab 12 117 103 1/7/2014 plasmid 2
A16 C Jul 5!6 58 M vanB 32 rectal swab 1 80 104 22/6/2014 plasmid 4
A17 C Jul 5!6 54 M vanB 8 rectal swab 1 80 104 28/6/2014 plasmid 4
A18 C Jul 5!6 49 M vanB 8 faeces 12 117 103 30/6/2014 plasmid 2
A19 C Jul 5!6 65 F vanB 32 rectal swab 12 117 103 25/7/2014 plasmid 2
A20 C Jul 5!6 61 M vanB 0.5 rectal swab 12 117 105 3/11/2014 chromosome 3
A21 D Nov 7 68 F vanB 32 rectal swab 1 80 104 29/10/2014 plasmid 4
A22 D Nov 7 62 M vanA! vanB 32 faeces 1 80 106 31/10/2014 plasmid 4
A22.1 D Nov 7 62 M vanA! vanB 32 rectal swab 1 80 106 4/11/2014 plasmid 4
A23 D Nov 7 66 F vanB 8 rectal swab 1 80 104 4/11/2014 plasmid 4
A24 D Nov 7 66 F vanB 1 rectal swab 1 80 104 4/11/2014 plasmid 4
A25 D Nov 7 70 M vanB 1 rectal swab 1 80 104 4/11/2014 plasmid 4
A26 D Nov 7 59 M vanB 8 rectal swab 1 80 104 4/11/2014 plasmid 4
A27 D Nov 7 50 M vanA! vanB 32 rectal swab 1 80 106 18/11/2014 plasmid 4
A28 D Nov 7 56 F vanB 8 rectal swab 1 80 104 19/11/2014 plasmid 4
A29 E Nov 2 57 M vanB 32 rectal swab 12 117 103 1/12/2014 plasmid 2
A30 E Nov 2 66 M vanB 32 rectal swab 12 117 103 2/12/2014 plasmid 2
A31 E Nov 2 60 F vanB 8 rectal swab 12 117 103 16/12/2014 plasmid 2
A32 F Dec 4 64 M vanB 32 rectal swab 12 117 103 22/12/2014 plasmid 2
A33 F Dec 4 69 M vanB 32 rectal swab 12 117 103 28/12/2014 plasmid 2
A34 F Dec 4 87 M vanB 32 rectal swab 12 117 103 31/12/2014 plasmid 2
ND, not determined; VAN, vancomycin.
aMT type"MLVA type.
bCT" cluster type.
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(Genbank locus_taq: BO233_15550). The overall DNA sequence of
this transposon shared the lowest similarity in comparison with
the reference Tn1549/Tn5382 transposon and differed by 261
SNPs.
Transposon type 3 was detected in the single isolate of CT105
(A20). The transposon was located on the bacterial chromosome
integrated between two genes; lacI (Genbank locus_taq:
BO233_10750) and a gene encoding a hypothetical protein
(GenBank locus_taq: BO233_10755). This transposon was
similar to the reference Tn1549/Tn5382 transposon, differing by
100 SNPs. In this transposon, two previously unreported regions
were detected. A region of 2677 bp was integrated into the gene
encoding a TrsK-like protein and contained a gene encoding an
RNA-directed DNA polymerase sharing 99% amino acid similarity
with Clostridioides difficile (NCBI Reference Sequence:
WP_044491975.1) The second region of 2434 bp was integrated
into an Rlx-like protein and contained a gene probably responsible
for encoding a group II intron reverse transcriptase/maturase.
Interestingly, protein blast analysis revealed substantial (97%)
amino acid similarity with a new identified protein homologous to
a protein present in Faecalibacterium spp. (NCBI Reference
Sequence: WP_087366583.1).
Transposon type 4 was detected in all CT104 (n"8) and CT106
(n"3) isolates. This transposon was located on a plasmid and
integrated into the DNA polymerase III epsilon subunit gene. The
transposon differed by 81 SNPs from the reference transposon and
contained a novel IS, IS285, present downstream of vanX. This in-
sertion sequence is related to Ruminococcus spp. as there was
98% amino acid identity with the IS256 family transposase of
Ruminococcaceae bacterium cv2 (NCBI Reference Sequence:
WP_055079492.1).
Combining epidemiological data, cgMLST and
transposon characterization
The analysis by cgMLST of all isolates showed clustering based on
genetic relatedness of isolates which were initially grouped into
different outbreak events. Isolates within CT103 belonged to out-
break clusters A, B, C, E and F, but clustered together based on
cgMLST. In addition, the identical type 2 transposon was detected
in VREfm from 10 patients that were previously grouped into differ-
ent outbreak clusters B, C, E and F. To elucidate this observation,
we attempted a more detailed analysis by combining epidemio-
logical data and visualization of patient transfer data and bed
occupancies in our epidemiological program, as well as cgMLST
and transposon analysis. Figure 3 shows the transfers/movements
of eight patients within and between four different hospital wards
over time that were found to carry VREfm with the identical type 2
transposon. By this approach, we identified overlaps in time and
wards linking the patients A13, A15 and A29–A34. No direct epi-
demiological links were found between patients A18 and A19
compared with the other patients carrying VREfm with the type 2
transposon.
Taking all the results together it was concluded that most likely
three VREfm outbreaks took place (Figure 4). The first outbreak

































































Outbreak investigation A April ward 1
Outbreak investigation B July ward 1
Outbreak investigation C July wards 5 and 6
Outbreak investigation D November ward 7
Outbreak investigation E November ward 2
Outbreak investigation F December ward 4
CT104
Figure 1. Minimum spanning tree based on cgMLST (1423 target genes). The different colours indicate the six different outbreak investigations based
on epidemiological data. Numbers indicate patients. Patients 4 and 22 had two samples included, indicated as samples A4 and A4.1 and samples
A22 and A22.1, respectively. The numbers next to the lines correspond to allele differences between the isolates. ST, blue; CT, black. This figure
appears in colour in the online version of JAC and in black and white in the print version of JAC.
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including a case of within-patient transfer (patient A4) to CT103.
A second outbreak was caused by isolates belonging to CT103 with
transposon type 2. The third outbreak was associated with isolates
of CT104 and CT106 connected by horizontal transfer of trans-
poson type 4. All other isolates represented individual cases.
Discussion
In this study, WGS and epidemiological data obtained from VREfm
isolates during outbreaks in 2014 in our region were retrospectively
analysed. Characterization of vanB-carrying transposons in VREfm
isolates was shown to be of additional value in the outbreak inves-
tigation. Transposon analysis is essential in cases where outbreaks
are caused by the movement of particular MGEs. The horizontal
transfer of vanB-carrying transposons was identified in two out-
break events. First, it was shown to occur within an individual pa-
tient, in whom isolates belonging to different clusters contained
an identical transposon. Second, patients from outbreak investiga-
tion D belonging to different CTs (CT104 and CT106) carried VREfm
isolates harbouring the same transposon. Thus, this study clearly
shows the importance of vanB transposon investigation. VREfm
isolates belonging to identical CTs defined by cgMLST can acquire
different vanB-carrying transposons de novo, which can be incor-
rectly interpreted based on cgMLST only. Although this situation
only occurred in one patient in our study, this phenomenon has al-
ready been described8,27 and we hypothesize that this will be
observed more often if VREfm outbreak analysis also includes
transposon investigation. In contrast, VREfm isolates belonging to
different CTs can also harbour the same vanB transposon and
thereby belong to the same outbreak cluster. Other studies have
also explicitly shown the importance of transferable MGEs in
VREfm outbreaks.4,8,27,28 Molecular typing methods such as MLVA
and MLST are used in the analysis of VREfm outbreaks and for epi-
demiological surveillance.11,29–32 However, these methods only
allow investigation of clonal spread, as is also the case with
cgMLST alone. These methods will fail in the case of outbreaks
being further complicated by horizontal gene transfer of MGE, such
as mediated by plasmids and/or transposons.
We observed the presence of the same vanB transposon in
VREfm isolates belonging to distinct lineages, showing exchange
of genomic material between VREfm and VSEfm. We also found














































































































































































































































































































Figure 2. The four different vanB transposons in comparison with the reference Tn1549. Transposons are numbered as in Figure 4. All transposons
have their unique insertion sites into different genes as indicated on both sides. Transposons 1 and 3 are located on the chromosome, whereas trans-
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they originated from other species and the presence of ISs origi-
nating from anaerobic bacteria, which indicates transposon acqui-
sition from the anaerobic gut microbiota by VSEfm. The occurrence
of these two events are both important factors in the emergence
of (vanB) VREfm.
In addition to the detection of horizontal gene transfer, this study
shows that transposon analysis also increases the discriminatory
power of WGS compared with only using the data for cgMLST. On
the other hand, cgMLST provides a higher discriminatory power than
MLVA and MLST typing only. It is able to distinguish genetically
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Positive VRE culture Patient transfer Patient discharged and subsequently admitted
Figure 3. Patient movements among four different wards during the period from May until the end of December 2014. The figure shows the move-
ments of patients A13, A15 and A29–A34. The numbers indicate the patients: 1, A13; 2, A29; 3, A15; 4, A31; 5, A30; 6, A32; 7, A34; and 8, A33. On the
right, the four different wards including the different room numbers (R) and beds (B) are shown. This figure appears in colour in the online version of
































































Figure 4. Minimum spanning tree based on cgMLST (1423 target genes). In contrast to Figure 1, colours now indicate the four different vanB trans-
poson types (numbered in colour, 1–4). Isolates from A9 and A14 were excluded due to the loss of the vanB gene. Patient A4 and patient A22 had
two samples included in the analysis (samples A4 and A4.1, and A22 and 22.1 respectively). The numbers next to the lines correspond to allele differ-
ences between the isolates. This figure appears in colour in the online version of JAC and in black and white in the print version of JAC.
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closely related isolates even if they belong to the same ST lineage.
This was the case for ST80 and ST117 in our study, each divided into
three different CTs. Both ST117 and ST80 are frequently found in
hospitals, are associated with outbreaks,33–38 and typically belong
to the HA clade A.39,40 cgMLST analysis also allows inter-laboratory
exchange of typing data. This is important as the exchange of
patients between hospitals and hospital units can contribute to the
spread of VREfm within healthcare networks. Indeed, using cgMLST
allowed us not only to show clonal spread within our own hospital,
but also intra-regional spread via a connected hospital in our health-
care region. Recent studies from Denmark and England, where WGS
for VREfm isolates was used as well, have also shown VREfm trans-
mission within a healthcare network.11,27,41 Therefore, it is wise to
set up a local healthcare network surveillance programme by identi-
fying healthcare facilities that are most connected by patient traffic
to allow optimal regional infection prevention measures. Such net-
works are currently recommended by the Ministry of Health,
Wellbeing and Sports in the Netherlands and one is already well
established in our healthcare region.42
Collecting epidemiological information is crucial to understand
the transmission pathways during an outbreak.30,43 However, pa-
tient transfers can be quite complicated to follow, as is shown in
our study. Although an epidemiological link could be found for the
majority of patients included in this study, some of the transmis-
sion pathways were still not fully understood. This could partially
be explained by the fact that we were not able to sequence all
VREfm isolates present in all patients involved in the outbreak
investigations during the implementation of WGS in 2014.
Moreover, data were not always directly available. Nowadays, WGS
is fully implemented as a standardized typing method for VRE in
our institute and we have speeded up the turnaround time to 48 h
(from culture to WGS data). Ideally, all WGS data should not only
be used for cgMLST typing, but also in parallel for transposon ana-
lysis. Preferably, to create a complete picture of the outbreaks, all
VREfm-positive patients should have their isolates sequenced and
included in the cgMLST analysis. Indeed, based on these prelimin-
ary results, we have now implemented WGS for every new VREfm
isolate per patient. Because of horizontal gene transfer, it should
also be considered to include several/all VREfm isolates per patient
in outbreak investigations. This can lead to a further increase in the
already enormous costs of outbreak investigations. However,
advances in sequencing technologies and analysis tools increases
the output, speeds up the analysis and reduces the costs of WGS
and by allowing for more focused infection control measures it
may reduce overall costs.14,15,44 This will lead to an increasing ap-
plication of WGS, which is of great value in outbreak analysis.
In conclusion, this study shows that although cgMLST provides
a high discriminatory power in the epidemiological analysis of
VREfm, transposon analysis increases the power of WGS and
allows the detection of horizontal gene transfer. Combining these
two methods allows investigation of both clonal spread as well as
concomitant spread of MGEs which will lead to better insights into
and understanding of the highly complex transmission routes dur-
ing in-hospital and regional VREfm outbreaks.
Funding




Table S1 appears as Supplementary data at JAC Online.
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